Milestone Scientific Inc.
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.8M | $2.2M | $2.1M | $2.4M | $2.3M | $2.2M | $2.0M | $2.5M |
| Cost of Revenue | $930.9K | $598.0K | $556.3K | $719.2K | $705.9K | $585.0K | $502.5K | $677.6K |
| Gross Profit | $1.9M | $1.6M | $1.5M | $1.6M | $1.6M | $1.6M | $1.5M | $1.8M |
| Gross Margin | 67.2% | 72.3% | 73.0% | 69.5% | 69.6% | 73.8% | 75.0% | 73.0% |
| Operating Expenses | ||||||||
| Research & Development | $6.6K | — | $12.3K | $16.2K | $51.8K | $369.1K | $217.5K | $232.1K |
| SG&A Expense | $2.9M | $2.4M | $2.5M | $2.7M | $3.0M | $3.3M | $3.3M | $3.1M |
| Operating Income | $-1.1M | $-828.1K | $-1.1M | $-1.1M | $-1.5M | $-2.0M | $-2.0M | $-1.5M |
| Operating Margin | -37.4% | -38.3% | -52.5% | -48.1% | -63.9% | -89.5% | -101.4% | -58.4% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $-1.1M | $-839.9K | $-1.1M | $-1.2M | $-1.5M | $-2.0M | $-2.0M | $-1.5M |
| Income Tax Expense | — | — | — | — | $0 | — | — | — |
| Net Income | $-1.1M | $-839.9K | $-1.1M | $-1.2M | $-1.5M | $-2.0M | $-2.0M | $-1.5M |
| Net Margin | -37.3% | -38.8% | -53.0% | -48.9% | -63.8% | -89.3% | -101.1% | -58.1% |
| EPS (Basic) | $-0.01 | $-0.01 | $-0.02 | $-0.01 | $-0.02 | $-0.02 | $-0.02 | $-0.02 |
| EPS (Diluted) | $-0.01 | $-0.01 | $-0.02 | $-0.01 | $-0.02 | $-0.02 | — | $-0.02 |
| Shares Outstanding (Basic) | 93.1M | 85.0M | 82.1M | 82.3M | 82.0M | 81.9M | 79.8M | 80.0M |
| Shares Outstanding (Diluted) | 93.1M | 85.0M | 82.1M | 82.3M | 82.0M | 81.9M | 79.8M | 80.0M |
| Dividends Per Share | — | — | — | — | — | — | — | — |